ArticleImmunologic research2026
Emapalumab plus conventional therapy with or without ruxolitinib for pediatric hemophagocytic lymphohistiocytosis: a single center retrospective study.
Meiling Liao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.